ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney"

  • 2022 American Transplant Congress

    Enhanced Delivery of Nanomedicine to Human Kidney During Ex Vivo Perfusion

    C. Albert1, L. Bracaglia1, A. Koide2, J. R. DiRito1, T. Lysyy1, E. Christopher1, J. Grundler1, J. T. Langford1, D. Haakinson1, J. S. Pober1, W. M. Saltzman1, S. Koide2, G. Tietjen1

    1Yale University, new haven, CT, 2Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY

    *Purpose: An efficient delivery of therapeutic agents to graft endothelial cells (ECs) prior to transplantation could render organs more resistant to injury, improving clinical outcomes…
  • 2022 American Transplant Congress

    Impact of ATG Dose Reduction on Kidney Transplant Outcomes During the Covid-19 Pandemic

    P. A. Than1, F. De Leon1, K. Jen2, N. Goussous1, R. V. Perez1, A. X. Wang3

    1Transplant Surgery, UC Davis, Sacramento, CA, 2Pathology, UC Davis, Sacramento, CA, 3Transplant Nephrology, UC Davis, Sacramento, CA

    *Purpose: During the COVID-19 pandemic, many transplant centers modified induction immunosuppression regimens. Beginning December 2020, our center reduced anti-thymocyte globulin (ATG) protocol dosing by up…
  • 2022 American Transplant Congress

    Novel Avenue of Allograft Monitoring: Direct Measurement of Donor-Derived Extracellular Vesicles in Human Plasma

    W. W. Woud, D. A. Hesselink, M. J. Hoogduijn, C. C. Baan, K. Boer

    Internal Medicine, Erasmus MC Transplant Institute, Rotterdam, Netherlands

    *Purpose: Extracellular Vesicles (EV) - regarded as “snapshots” of their cell of origin - represent promising liquid biomarkers to monitor allograft function post transplantation. Recently,…
  • 2022 American Transplant Congress

    Status 7: Parking Lot or Loading Zone?

    E. Wells, M. Robinson, S. Blais, A. Chacon, S. Greve, R. Villicana, C. Bratton, K. Talavera, M. de Vera, S. Regmi, T. Hoang, J. Woloszyn, R. Rattanavich

    Transplant Institute, Loma Linda University Health, Loma Linda, CA

    *Purpose: Kidney waitlist management continues to be a challenge for many transplant centers for a variety of reasons. Over the years, the number of Status…
  • 2022 American Transplant Congress

    Prevention of the Progression in Chronic Calcineurin Inhibitors Nephrotoxicity via Steroids Anti-Inflammatory Effects

    N. Iwahara1, K. Hotta1, Y. Tanaka1, I. Takahashi1, R. Hasebe1, H. Okada1, T. Tsuji2, Y. Takada2, H. Higuchi2, H. Sasaki1, T. Tanabe1, D. Iwami3, N. Shinohara1, M. Murakami1

    1Hokkaido Univercity, Sapporo, Japan, 2Sapporo City General Hospital, Sapporo, Japan, 3Jichi Medical University, Shimotsuke, Japan

    *Purpose: Calcineurin inhibitors (CNI) lead to an excellent short-term kidney allograft outcome. However, chronic nephrotoxicity is a major concern, which affects a long-term allograft survival.…
  • 2022 American Transplant Congress

    Early Experience with 4-drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients

    S. Mouawad1, C. Shoemaker2, J. Geyston3, A. Nishio Lucar3

    1University of Virginia Health System, Charlottesville, VA, 2Pharmacy, UVA Health, Charlottesville, VA, 3University of Virginia, Charlottesville, VA

    *Purpose: Belatacept based immunosuppression regimens in kidney transplant recipients have been associated with better kidney function, improved metabolic profile, less de novo DSA formation and…
  • 2022 American Transplant Congress

    What If Only Days After Dialysis Counted Towards Kidney Candidates’ Qualified Waiting Times?

    G. R. Vece, K. Lindblad, M. Stuart, B. Carrico, D. Stewart, D. Klassen, S. Diallo

    Research, United Network for Organ Sharing, Richmond, VA

    *Purpose: Current kidney policy allows patients who have not yet initiated dialysis to qualify for allocation priority based on the time since a recorded eGFR…
  • 2022 American Transplant Congress

    The Correlation Between Kidney Donor Risk Index, Kidney Graft Function and Histological Changes in Early Post-Transplant Renal Biopsy

    N. Slabiak-Blaz, A. Kujawa-Szewieczek, A. Kolonko, H. Karkoszka, A. Wiecek, G. Piecha

    Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland

    *Purpose: An appropriate assessment of donor organ quality is crucial to optimize the kidney allocation and improve the long-term outcomes. Kidney Donor Risk Index (KDRI),…
  • 2022 American Transplant Congress

    Characterizing the Landscape of Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

    J. D. Motter1, K. Jackson1, K. Yu2, R. M. Pfeiffer2, A. Massie1, J. Garonzik-Wang3, D. Segev1, E. A. Engels2

    1Johns Hopkins University, Baltimore, MD, 2National Cancer Institute, Bethesda, MD, 3University of Wisconsin-Madison, Madison, WI

    *Purpose: Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation across donor-specific antibody (DSA); however, this substantial upfront immunosuppression may result in…
  • 2022 American Transplant Congress

    Incidence of De Novo Donor Specific Antibodies After Early Steroid Withdrawal in Kidney Transplant Recipients

    D. Majmundar, S. Karhadkar, A. Diamond, J. Au, C. Ruggia-Check

    Temple University Hospital, Philadelphia, PA

    *Purpose: Early steroid withdrawal (ESW) regimens may lead to the formation of de novo donor-specific antibodies (dnDSA) post-kidney transplant, which increases the risk of antibody-mediated…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 101
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences